Faster access than browser!Similarities between Proton-pump inhibitor and Ranbaxy Laboratories
Proton-pump inhibitor and Ranbaxy Laboratories have 3 things in common (in Unionpedia): Food and Drug Administration, Medication, Pantoprazole.
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Food and Drug Administration and Proton-pump inhibitor · Food and Drug Administration and Ranbaxy Laboratories ·
Medication
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease.
Medication and Proton-pump inhibitor · Medication and Ranbaxy Laboratories ·
Pantoprazole
Pantoprazole, first sold under the brand name Protonix, is used for short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, and pathological hypersecretory conditions including Zollinger–Ellison syndrome.
Pantoprazole and Proton-pump inhibitor · Pantoprazole and Ranbaxy Laboratories ·
The list above answers the following questions
- What Proton-pump inhibitor and Ranbaxy Laboratories have in common
- What are the similarities between Proton-pump inhibitor and Ranbaxy Laboratories
Proton-pump inhibitor and Ranbaxy Laboratories Comparison
Proton-pump inhibitor has 95 relations, while Ranbaxy Laboratories has 32. As they have in common 3, the Jaccard index is 2.36% = 3 / (95 + 32).
References
This article shows the relationship between Proton-pump inhibitor and Ranbaxy Laboratories. To access each article from which the information was extracted, please visit:
